The pharmacological phenotype of ATP-sensitive potassium (KATP) channels is defined by their tissue-specific regulatory subunit, the sulfonylurea receptor (SUR), which associates with the pore-forming channel core, Kir6.2. The potassium channel opener diazoxide has hyperglycemic and hypotensive properties that stem from its ability to open K ATP channels in pancreas and smooth muscle. Diazoxide is believed not to have any significant action on cardiac sarcolemmal K ATP channels. Yet, diazoxide can be cardioprotective in ischemia and has been found to bind to the presumed cardiac sarcolemmal K ATP channel-regulatory subunit, SUR2A. Here, in excised patches, diazoxide (300 M) activated pancreatic SUR1͞ Kir6.2 currents and had little effect on native or recombinant cardiac SUR2A͞Kir6.2 currents. However, in the presence of cytoplasmic ADP (100 M), SUR2A͞Kir6.2 channels became as sensitive to diazoxide as SUR1͞Kir6.2 channels. This effect involved specific interactions between MgADP and SUR, as it required Mg 2؉ , but not ATP, and was abolished by point mutations in the second nucleotide-binding domain of SUR, which impaired channel activation by MgADP. At the whole-cell level, in cardiomyocytes treated with oligomycin to block mitochondrial function, diazoxide could also activate K ATP currents only after cytosolic ADP had been raised by a creatine kinase inhibitor. Thus, ADP serves as a cofactor to define the responsiveness of cardiac K ATP channels toward diazoxide. The present demonstration of a pharmacological plasticity of K ATP channels identifies a mechanism for the control of channel activity in cardiac cells depending on the cellular ADP levels, which are elevated under ischemia.
T he potassium channel-opening drug (KCO) diazoxide has been in clinical use for the treatment of persistent hyperinsulinemia and hypertensive emergencies (1) . Its pharmacodynamic properties have been related to the opening of ATPsensitive potassium (K ATP ) channels present in pancreatic ␤-cells and smooth muscle, where these channels regulate insulin secretion and vascular tone (2, 3) . Plasma membrane K ATP channels are constituted of an inward rectifier K ϩ channel, Kir6.2, associated with a regulatory subunit, the sulfonylurea receptor (SUR) (4) (5) (6) . SUR, a member of the ATP-binding-cassette (ABC) transporter family, is the primary target of the KCOs (7) (8) (9) . It is now established that the nucleotide-binding domains of SUR are tightly linked to the sites of action of KCOs because binding and effects of KCOs require hydrolyzable nucleotides and are compromised by mutations that, in other ABC transporters, impair the ability of these domains to bind and hydrolyze nucleotides (8) (9) (10) (11) . Several isoforms of SUR have been identified, including SUR1 in pancreatic ␤-cells (4, 5) and SUR2B in smooth muscle (12) .
In addition to its hyperglycemic and hypotensive properties, diazoxide also has the ability to protect ischemic myocardial tissue (13) , which expresses SUR2A, the presumed cardiac isoform of SUR (14) . However, it has been difficult to demonstrate any stimulatory effect of diazoxide on plasmalemmal cardiac K ATP channels, either in their native form (15) or after reconstitution by heterologous coexpression of Kir6.2 and SUR2A (14, 16, 17) . It has, therefore, become an established dogma that diazoxide does not act on cardiac sarcolemmal K ATP channels (18) (19) (20) . This has given weight to the hypothesis that diazoxide could produce some of its cardioprotective effects through activation of mitochondrial, rather than plasmalemmal, K ATP channels (13, 21) .
Binding experiments, however, have demonstrated that diazoxide can interact not only with SUR1, but also with SUR2A itself (8) . Moreover, some reports have described a diazoxideinduced shortening of the cardiac action potential and͞or an increase in whole-cell currents (13, 22, 23) , suggesting that conditions exist where diazoxide could activate cardiac Kir6.2͞ SUR2A channels, much like pancreatic Kir6.2͞SUR1 channels.
Here, we report that increase in cytoplasmic MgADP is the condition required for diazoxide to activate cardiac K ATP channels, both native and recombinant. This implies that the transduction steps linking opener binding and channel opening are regulated by nucleotide interaction with the nucleotide-binding domains not only in the SUR1 protein (10, 11) , but also in SUR2A. As the ischemic myocardium is characterized by increased levels of cytosolic ADP, an ADP-dependent activation of cardiac K ATP channels by diazoxide could be relevant to its overall cardioprotective action.
A preliminary account of this work has been published in abstract form. ¶ (24) . After amplification and linearization, plasmid DNAs were transcribed in vitro by using the T7 mMessage mMachine kit (Ambion, Austin, TX). cRNAs were electrophoresed on formaldehyde gels, and concentrations were estimated from two dilutions by using RNA marker as a standard. Mutagenesis of SUR2A was done directly on the plasmid pGEMHE-SUR2A by PCR amplification of both DNA strands with complementary primers mutated to produce The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Materials and Methods
the desired amino acid change (QuickChange site-directed mutagenesis kit; Stratagene). The primers, 5Ј-CCGGTAGTGG-GATGAGCTCTCTATCTCTGG-3Ј for the K1348M mutation and 5Ј-GCAGCATACTGATCATGAATGAGGCCACGGCC-TCC-3Ј for D1469N, also incorporated the new restriction sites SacI and BclI to facilitate screening of the correct constructs. These constructs were sequenced to confirm the mutations.
Xenopus laevis were anaesthetized with 3-aminobenzoic acid ethyl ester (1 g͞liter of water). Part of one ovary was removed, the incision was sutured, and the animal was allowed to recover. Stage V or VI oocytes were defolliculated by an Ϸ60-min incubation at 19°C with 2 mg͞ml type A collagenase (Sigma). Selected oocytes were injected the next day with 50 nl of water containing Ϸ2 ng of Kir6.2 cRNA and with Ϸ6 ng of cRNA encoding SUR1 or SUR2A. They were stored at 19°C in a modified Barth's solution with (in mM): 1 KCl, 0.82 MgSO 4 , 88 NaCl, 2.4 NaHCO 3 , 0.41 CaCl 2 , 0.3 Ca(NO 3 ) 2 , and 16 Hepes (pH 7.4) supplemented with 100 units͞ml penicillin, 100 g͞ml streptomycin, and 100 g͞ml gentamycin.
Three to 15 days after injection, oocytes were devitellinized, and heterologously expressed K ATP channels were characterized by the patch-clamp technique in the excised inside-out configuration (25) by using techniques similar to those we used to record native frog skeletal muscle K ATP channels (26, 27) .
Conditions were designed to optimize recording of K ATP currents and minimize contributions by endogenous oocyte Cl Cardiac Myocytes. Guinea pig ventricular myocytes were isolated by enzymatic dissociation as described (28) . For inside-out patch-clamp recordings, fire-polished pipettes (5-7 M⍀) contained (in mM): 140 KCl, 1 CaCl 2 , 1 MgCl 2 , 5 Hepes-KOH (pH 7.3), whereas the bath solution had (in mM): 140 KCl, 1 MgCl 2 , 5 EGTA, 5 Hepes-KOH (pH 7.3). Currents were monitored on-line on a high-gain digital storage oscilloscope (VC-6025; Hitachi, Tokyo) and stored on tape with a digital data recorder (VR-10; Instrutech, Mineola, NY). Currents were filtered offline at 1 kHz with a Bessel filter (Frequency Devices 902; Haverhill, MA), sampled at 150-s intervals, and analyzed by using the BIOQUEST software (28) . For whole-cell recordings, cardiomyocytes were superfused with a Tyrode solution containing (in mM): 136.5 NaCl, 5.4 KCl, 1.8 CaCl 2 , 0.53 MgCl 2 , 5.5 glucose, and 5.5 Hepes-NaOH (pH 7.4). Pipettes (Ϸ5 M⍀) for whole-cell recording contained (in mM): 140 KCl, 1 MgCl 2 , 2 ATP, 5 EGTA, and 10 Hepes-KOH (pH 7.3).
Materials. ATP and ADP (potassium salts; Sigma), diazoxide (100 mM stock in DMSO; Sigma), oligomycin (a mixture of oligomycins A, B, and C; 1 mg͞ml stock in DMSO; Sigma), and 2, 4-dinitro-1-fluorobenzene (DNFB; Fluka) were added as specified. All recordings were done at room temperature (Ϸ22°C). Results are displayed as mean Ϯ SEM.
Results

Activation of SUR2A͞Kir6.2 by Diazoxide in the Presence of ADP.
Within 3 days after injection of Xenopus oocytes with cRNAs coding for Kir6.2 and either SUR1 or SUR2A, macroscopic K ATP currents could be recorded in excised inside-out patches. SUR1 and SUR2A͞Kir6.2 channels exhibited similar sensitivities to inhibition by intracellular ATP, with 10-20 M ATP causing half-inhibition on average (9) .
When currents were blocked to about 15% of their maximal values by 100 M ATP, diazoxide (300 M) caused a 5-fold increase in SUR1͞Kir6.2 currents but had little effects on SUR2A͞Kir6.2 currents (Fig. 1) . However, in the presence of 100 M ADP, diazoxide caused a robust increase in current, regardless of whether SUR1 or SUR2A was expressed. At 100 M, ADP produced a 3-fold stimulation of ATP-inhibited SUR1 or SUR2A͞Kir6.2 currents. On top of this stimulation, diazoxide further activated currents more than 3-fold (3.8 Ϯ 0.4 for SUR1 and 3.6 Ϯ 0.7 for SUR2A). Therefore, ADP uncovers a previously unrecognized ability of SUR2A͞Kir6.2 channels to respond to diazoxide.
Nucleotide Requirements for Diazoxide Activation of SUR2A͞
Kir6.2 Channels. For SUR2A͞Kir6.2 channels, there is a sharp dependence of the effect of diazoxide on the concentration of ADP (Fig. 2B) , with channel activation by diazoxide becoming significant only at or above 100 M ADP. For SUR1͞Kir6.2 Fig. 2 A) , diazoxide-induced activity is already vigorous in the absence of added ADP and is enhanced progressively by further addition of 10 and 100 M ADP. For both channel isoforms, the sensitivity to ADP alone appeared equivalent, with slight activation at 10 M and large activation at 100 M (Fig. 2C) .
channels (
The experiments described in Figs. 1 and 2 were performed with both ATP and Mg 2ϩ present. In the absence of ATP and presence of Mg 2ϩ (1 mM), when the concentration of ADP was raised to 1 mM, which partially blocked K ATP current, diazoxide (300 M) activated SUR2A͞Kir6.2 currents to the maximum level observed in the absence of nucleotides ( Fig. 3A; fold increase ϭ 2.03 Ϯ 0.4; n ϭ 5). After removal of Mg 2ϩ and in the presence of EDTA, diazoxide could not increase channel activity despite the presence of 1 mM ADP (Fig. 3B) , suggesting that MgADP, rather than ADP alone, is required for opener-induced activation of SUR2A͞Kir6.2 channels. ion to interact with the ␤-and ␥-phosphates of ATP (30) . In SUR1, mutations of these residues in both NBDs disrupt the channel response to ADP and diazoxide (10, 11) . Mutations in NBD1 eliminate ATP binding, whereas equivalent mutations in NBD2 only impair the ability of MgADP to antagonize ATP binding (31) , suggesting that the NBD2 domain is responsible for the interaction between SUR1 and MgADP. The role of NBD2 in MgADP-dependent diazoxide action on SUR2A͞Kir6.2 channels was directly tested in channels with mutated Walker A lysine (K1348M) and Walker B aspartate (D1469N) residues. These two SUR2A mutants, when coexpressed with Kir6.2, produced functional channels with a sensitivity to ATP similar to that observed in the wild type (Fig. 4) . However, these mutants produced channels with an impaired sensitivity to MgADP (Fig. 4) , consistent with a critical role for NBD2 in mediating the interaction of ADP with SUR2A. In these mutants, the lack of sensitivity to ADP was associated with the inability of diazoxide to activate the channels alone or in the presence of MgADP (Fig. 4) .
Diazoxide Activates Native Cardiac KATP Channels. SUR2A is the proposed cardiac isoform of SUR (14) (15) (16) (17) , and the ADP requirement for diazoxide-induced channel activation should be reproducible with the channel expressed in its native environment. Diazoxide was therefore tested on K ATP channels in membranes of ventricular myocytes. Like SUR2A͞Kir6.2 channels, native cardiac K ATP channels were blocked by 300 M ATP and activated by 100 M ADP (Fig. 5A ). In the presence of ADP, diazoxide (300 M) produced significant increase in channel activity, which was only marginal in the absence of ADP. On average, the effect of diazoxide in the absence of ADP was equivalent in native channels and recombinant SUR2A͞Kir6.2 channels (fold increases of 1.79 Ϯ 0.35, n ϭ 8, and 1.51 Ϯ 0.14, n ϭ 20, respectively). Such effect could be because of vehicle (see Fig. 1C ) and͞or possible presence of contaminant ADP in the ATP solutions. In the presence of ADP, diazoxide in native channels produced significant activation, albeit the relative increase in native channel activity was smaller than that observed in recombinant channels (fold increases of 2.15 Ϯ 0.52, n ϭ 8, vs. 3.56 Ϯ 0.71, n ϭ 14). This apparent difference in efficacy might not reflect a real variance in the responsiveness of native vs. recombinant channels. It could be because of saturation of the effect of diazoxide in native channels operating, in the presence of ADP, at levels beyond which even more effective activators could not produce a more pronounced channel activation.
In contrast to inside-out patches, in the intact cardiomyocytes, K ATP channels are coupled to intracellular ATP-consuming͞ ATP-generating systems (32) . Under such conditions, the efficacy of diazoxide will depend on the availability of ADP at the channel site. In cardiomyocytes treated with the mitochondrial ATP-synthase inhibitor oligomycin, diazoxide did not activate K ATP channel current (Fig. 6 ). This suggests that, in addition to mitochondrial ADP consumption, other catalytic activities recycle ADP into ATP. This may include creatine kinase, which is responsible for 90% of ATP turnover in cardiac cells (33) . Therefore, we added to oligomycin-treated cardiomyocytes the creatine kinase inhibitor DNFB, which, on its own, induced modest channel activation (Fig. 6) , suggesting that, with inhibited creatine kinase, levels of ADP were raised. Further application of diazoxide produced vigorous increase in outward current, in line with a diazoxide-induced activation of K ATP current (Fig. 6) . The diazoxide-induced outward current partially reversed on washout (Fig. 6 A and B) and was observed at both ϩ10 mV, where outward and inward current components are not separated, and Ϫ50 mV, where the inward current component is essentially inactivated (Fig. 6A) . Thus, after inhibition of cellular ADP-utilizing systems, diazoxide can enhance whole-cell K ATP current.
Discussion
Diazoxide has a special place among KCOs, as it displays an apparently high selectivity for pancreatic ␤-cell and smooth muscle over cardiac K ATP channels. In isolated patches from cardiac muscle cells or from cells expressing recombinant SUR2A͞Kir6.2 channels, a stimulatory effect of diazoxide has never been reported to date, leading to the consensus opinion that cardiac sarcolemmal K ATP channels are insensitive to this drug (18-21) . Present results demonstrate that diazoxide can produce activation of cardiac K ATP channels with ADP serving as an essential cofactor in this phenomenon. Experimental evidence was obtained for both recombinant and native cardiac K ATP channels. In the absence of ADP, diazoxide caused only a slight activation of cardiac K ATP channels, which could have been overlooked in previous studies. This activation could have arisen from an effect of the vehicle, in our case DMSO, or from the presence of contaminant ADP, which cannot be avoided when solutions containing ATP are used. In the presence of 100 M ADP, diazoxide produced a large activation comparable to that seen with pancreatic Kir6.2͞SUR1 channels. The concentration threshold for this effect of ADP was between 10 and 100 M. This could explain the lack of clear effects of diazoxide on membrane currents from resting myocytes where the concentration of free ADP is maintained below the micromolar range by a number of ADP-utilizing processes, including the creatine kinase reaction (34) . Only after blocking ADP consumption could we observe a consistent increase in whole-cell K ATP currents by diazoxide. To ensure that diazoxide acted directly on sarcolemmal channels and not indirectly via mitochondrial channels (13, 21, 35) , in those experiments, cells were pretreated with oligomycin to disrupt mitochondrial function. The evidence thus shows that diazoxide will increase K ϩ currents in heart muscle only in conditions of elevated ADP levels as might occur under ischemic conditions (35) . This preference for sarcolemmal channels in metabolically compromised cells, combined with the activation of mitochondrial channels (13, 21, 36) , could contribute to the cardioprotective efficacy of diazoxide.
In terms of molecular structure, the observed correlation between native channels and SUR2A͞Kir6.2 supports the hypothesis that these two entities are identical (14, 16, 37) . Experiments showing that diazoxide can displace the binding of a radiolabeled opener from SUR2A (8) imply that SUR2A possesses a diazoxide binding site like other known isoforms of the SUR do. As binding experiments (8) were done in the absence of ADP, it would appear that ADP facilitates diazoxide activation by acting on the coupling between diazoxide and channel opening, rather than on the binding step. That Mg 2ϩ is required, but ATP is neither sufficient nor necessary to promote diazoxide action suggests, first, that ADP, produced through a possible (though still undemonstrated) hydrolysis of ATP by SUR, cannot replace exogenously supplied ADP, and second, that the mechanism involves the second NBD, NBD2, of SUR2A, which preferentially binds MgADP (31) . Corroborating this latter conclusion, mutations of the conserved lysine (to methionine) and aspartate (to asparagine) residues of the Walker A and B motifs of NBD2 abolished both ADP and diazoxide activation. In SUR1, the corresponding lysine-tomethionine mutation cancelled the activatory effects of ADP but not of diazoxide (10) , suggesting that an obligatory link between ADP and diazoxide exists in SUR2A but not SUR1.
In summary, we provide evidence for the critical role of intracellular ADP in defining the response of cardiac K ATP channel toward diazoxide. That cardiac K ATP channels can be rendered diazoxide-sensitive provides a mechanistic basis for the action of this opener on cardiac sarcolemmal K ATP channels. Along with previous reports of nucleotide diphosphatedependent action of channel openers (10, 11, 38) , as well as blockers (29, (39) (40) (41) (42) , the present study demonstrates a fundamental role for ADP in defining the pharmacological plasticity of K ATP channels.
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